# Dexmedetomidine-propofol-remifentanil Anaesthesia and Reactivity to Noxious Stimuli

> **NCT01076790** · PHASE4 · COMPLETED · sponsor: **Arvi Yli-Hankala** · enrollment: 44 (actual)

## Conditions studied

- Anaesthesia

## Interventions

- **DRUG:** Dexmedetomidine
- **DRUG:** Saline

## Key facts

- **NCT ID:** NCT01076790
- **Lead sponsor:** Arvi Yli-Hankala
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2009-11
- **Primary completion:** 2011-03
- **Final completion:** 2011-03
- **Target enrollment:** 44 (ACTUAL)
- **Last updated:** 2013-10-09


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01076790

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01076790, "Dexmedetomidine-propofol-remifentanil Anaesthesia and Reactivity to Noxious Stimuli". Retrieved via AI Analytics 2026-05-25 from https://api.ai-analytics.org/clinical/NCT01076790. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*